Sun Protection

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
1
Sunscreen Test Code: V53-028Phase 31 trial
Active Trials
NCT01001975Completed10Est. Aug 2009
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
SPF50+N/A1 trial
Active Trials
NCT02952235Completed199Est. Mar 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerSunscreen Test Code: V53-028
Johnson & JohnsonSPF50+

Clinical Trials (2)

Total enrollment: 209 patients across 2 trials

NCT01001975BayerSunscreen Test Code: V53-028

Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED)

Start: Jul 2009Est. completion: Aug 200910 patients
Phase 3Completed
NCT02952235Johnson & JohnsonSPF50+

Evaluation of Sunscreens Under Actual Use Conditions

Start: Mar 2016Est. completion: Mar 2016199 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space